Gary Lotz is a seasoned clinical and medical affairs executive with over 20 years of experience in global clinical research leadership, specializing in evidence generation for medical devices and health technologies. Most recently serving as Sr. Director of Global Clinical & Medical Affairs at Philips Respironics, Gary led a multidisciplinary team in executing over 100 studies annually, ensuring compliance with FDA, ISO, and EU MDR regulations. His background in physical therapy, paired with advanced degrees in science and business, uniquely positions him to translate clinical insight into strategic advantage. Gary is a trusted advisor to regulatory bodies, key opinion leaders, and industry stakeholders.

Jeremy Powers is an accomplished clinical project manager and development leader with over 20 years of global experience across major organizations like Philips Healthcare, emerging MedTech innovators, and early-stage startups. He combines deep clinical expertise with strong business insight to guide strategic decisions and deliver impactful clinical evidence that drives innovation, supports regulatory clearance, and builds stakeholder confidence. Known for his collaborative and results driven approach, Jeremy partners with cross-functional teams to design and execute clinical strategies that align with business goals and meet the highest standards of regulatory compliance. His leadership consistently advances product development, accelerates market access, and strengthens the value of clinical evidence across the product life cycle.

Chuck Cain has extensive experience in clinical development and operations specializing in evidence generation projects with over 20 years of global experience. Most recently, Chuck led Philips Respironics Sleep and Respiratory Care business as the Director of Clinical Affairs. He is an experienced clinical research leader with a proven track record of driving global clinical evidence strategies, leading cross-functional collaboration, and seamlessly integrating clinical activities with overarching business objectives. Recognized for fostering innovation, compliance, and efficiency in Clinical Affairs processes while mentoring teams to develop critical scientific thinking. Skilled in planning and executing clinical trials, managing budgets, and ensuring adherence to regulatory standards and Good Clinical Practice (GCP). Demonstrated expertise in evidence generation for New Product Introduction (NPI) and Life Cycle Management (LCM), with a strong focus on aligning clinical operations with corporate goals to deliver high-quality, impactful results.